Switch to:
Allergan PLC (NYSE:AGN)
EV/EBITDA
76.30 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Allergan PLC's enterprise value is $167,456 Mil. Allergan PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2015 was $2,195 Mil. Therefore, Allergan PLC's EV/EBITDA ratio for today is 76.30.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Allergan PLC's stock price is $312.00. Allergan PLC's earnings per share for the trailing twelve months (TTM) ended in Jun. 2015 was $-9.36. Therefore, Allergan PLC's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Allergan PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=167455.781/2194.8
=76.30

Allergan PLC's current Enterprise Value is $167,456 Mil.
Allergan PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2015 was -80.4 (Sep. 2014 ) + 270.9 (Dec. 2014 ) + 464.5 (Mar. 2015 ) + 1539.8 (Jun. 2015 ) = $2,195 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Allergan PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=312.00/-9.359
=

Allergan PLC's share price for today is $312.00.
Allergan PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2015 was -3.95 (Sep. 2014 ) + -2.759 (Dec. 2014 ) + -1.85 (Mar. 2015 ) + -0.8 (Jun. 2015 ) = $-9.36.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Allergan PLC Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda 8.11-21.926.715.6310.4711.718.6118.0157.9754.35

Allergan PLC Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
ev2ebitda 20.9142.8638.6257.9738.1222.0748.4554.35124.9274.73
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK